Skip to Main Content
Skip Nav Destination
Issue Cover
Current Issue
Volume 148,
Issue 3
March 2024
New Articles
Submit a Manuscript

Editor in Chief:
Alain C. Borczuk, MD

ISSN: 0003-9985
eISSN: 1543-2165

Impact Factor: 4.6

Recently Posted COVID-19 Articles

•  SARS-CoV-2 Serology Did Not Predict Risk of Breakthrough Infection During the Omicron BA.1 and BA.2 Surge

•  Risk Estimation of Severe COVID-19 Based on Initial Biomarker Assessment Across Racial and Ethnic Groups

•  The Prevalence of SARS-CoV-2 in Autopsies Surrounding the Time of Pandemic Onset: A Retrospective Review of Cases

•  Simple Saliva Sample Collection for the Detection of SARS-CoV-2 Variants Compared to Nasopharyngeal Swab Sample

•  Rapid Deployment of Whole Slide Imaging for Primary Diagnosis in Surgical Pathology at Stanford Medicine: Responding to Challenges of the COVID-19 Pandemic

•  Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients

•  Comparison of Mid-turbinate Nasal Swabs, Saliva and Nasopharyngeal Swabs for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction Testing in Pediatric Outpatients

•  In Reply

•  Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose

•  Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose: Cytokine storm, hypersensitivity, or something else

•  The role of sub-genomic RNA in discordant results from reverse transcription-polymerase chain reaction tests for COVID

•  Anti-Receptor-Binding Domain Immunoglobulin G Antibody as a Predictor of Seropositivity for Anti-SARS-CoV-2 Neutralizing Antibody

•  The Coronavirus Disease 2019 Grand Challenge: Setting Expectations and Future Directions for Community and Home Testing

•  Late Complications of COVID-19: A Morphologic, Imaging, and Droplet Digital Polymerase Chain Reaction Study of Lung Tissue

•  Comparison of Symptoms and Antibody Response Following Administration of Moderna or Pfizer SARS-CoV-2 Vaccines

•  Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose

•  Placental Tissue Destruction and Insufficiency from COVID-19 Causes Stillbirth and Neonatal Death from Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries

•  Longitudinal comparison of automated SARS-CoV-2 serology assays in assessing virus neutralization capacity in COVID-19 convalescent sera

•  Fetal deaths in Ireland due to SARS-CoV-2 placentitis caused by SARS-CoV-2 Alpha

•  Evolution of COVID-19 Testing and the Role of Rapid Antigen Testing in Molecular-Focused World

•  Home Antigen Test Recall Affects Millions: Beware False Positives, but Also Uncertainty and Potential False Negatives

•  Identifying Inconclusive Data in the SARS-CoV-2 Molecular Diagnostic Using Nucleocapsid Phosphoprotein Gene as Target


•  Elevated von Willebrand Factor Antigen is an Early Predictor of Mortality and Prolonged Length of Stay for Coronavirus Disease 2019 (COVID-19) Inpatients

•  Risk-Assessment of Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients Using Laboratory Data and Immune Cell Morphological Assessment

•  Early Antibody Temporal Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Vaccinated Subjects Determined by the Cobas 6000 Spike Assay

•  Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment

•  India's Second Wave of Coronavirus Disease 2019 (COVID-19) and the Lethal Outbreak of Black Fungus Infection

•  Hofbauer cells and coronavirus disease 2019 (COVID-19) in pregnancy: Molecular pathology analysis of villous macrophages, endothelial cells, and placental findings from 22 placentas infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without fetal transmission

•  A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases

•  The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology

•  Defining Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placentitis: A Report of 7 Cases with Confirmatory In Situ Hybridization, Distinct Histomorphologic Features, and Evidence of Complement Deposition

•  Future of Education or Present Reality: MD Anderson Cancer Center Hematopathology Virtual Educational Platform under Coronavirus Disease 2019 (COVID-19) Pandemic

•  Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays

•  Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method

•  Digital Pathology Initiatives and Experience of a Large Academic Institution During the Coronavirus Disease 2019 (COVID-19) Pandemic

•  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus, Intrauterine Transmission and Placental Pathology During the Coronavirus Disease 2019 (COVID-19) Pandemic: It's Complicated

•  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative IgG Assays: The Value of Numeric Reporting

•  Continuing Undergraduate Pathology Medical Education in the Coronavirus Disease 2019 (COVID-19) Global Pandemic: The Johns Hopkins Virtual Surgical Pathology Clinical Elective

•  Comparison of In Situ Hybridization, Immunohistochemistry and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2)-Testing in Tissue

•  The Impact of Increasing Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance

•  Histologic and Immunohistochemical Evaluation of 65 Placentas from Women with Polymerase Chain Reaction-proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

•  Inter-laboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program

•  A Postmortem Portrait of the Coronavirus Disease 2019 (COVID-19) Pandemic: A Large Multiinstitutional Autopsy Survey Study

Features & Information

Submissions Now Accepted for CAP24 Abstract Program

Abstract and case study submissions to the College of American Pathologists (CAP) 2024 Abstract Program will be accepted beginning at 9 a.m. Monday, January 8 through 5 p.m. Central time Monday, March 11, 2024.

Accepted submissions will appear on the Archives of Pathology & Laboratory Medicine web site as a web-only supplement to the September 2024 issue. Awards will be presented to the winners of the Top 5 Junior Member Abstract Program.

Click here for submission guidelines and a link to the CAP24 Abstract Program submission site.

Welcome to the Archives of Pathology & Laboratory Medicine Website

The Archives is the monthly, peer-reviewed medical journal of the College of American Pathologists. It offers global reach and the highest measured readership among pathology journals. Published since 1926, the Archives was voted in 2009 the only pathology journal among the top 100 most influential journals of the past 100 years by the Bio Medical and Life Sciences Division of the Special Libraries Association. Online access to the full-text and PDF files of Archives articles is free. The Archives is an official publication of the College of American Pathologists.

Register for a Profile

Not Yet Registered? While visitors to the Archives Web site are not required to register to have full access to published articles, the benefits of registration include:
• The ability to save searches for subjects that interest you
• The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers

Register Here

Close Modal

or Create an Account

Close Modal
Close Modal